|
1
|
Simonneau G, Gatzoulis MA, Adatia I,
Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar
R, Landzberg M, Machado RF, et al: Updated clinical classification
of pulmonary hypertension. J Am Coll Cardiol. 62 (25
Suppl):D34–D41. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiong PY, Potus F, Chan W and Archer SL:
Models and molecular mechanisms of world health organization group
2 to 4 pulmonary hypertension. Hypertension. 71:34–55. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi N and Chen SY: Mechanisms
simultaneously regulate smooth muscle proliferation and
differentiation. J Biomed Res. 28:40–46. 2014.PubMed/NCBI
|
|
4
|
Masudo K, Suganuma N, Nakayama H, Oshima
T, Rino Y, Iwasaki H, Matsuzu K, Sugino K, Ito K, Kondo T, et al:
EZH2 overexpression as a useful prognostic marker for aggressive
behaviour in thyroid cancer. In Vivo. 32:25–31. 2018.PubMed/NCBI
|
|
5
|
Simon JA and Lange CA: Roles of the EZH2
histone methyltransferase in cancer epigenetics. Mutat Res.
647:21–29. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang CJ and Hung MC: The role of EZH2 in
tumour progression. Br J Cancer. 106:243–247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rao ZY, Cai MY, Yang GF, He LR, Mai SJ,
Hua WF, Liao YJ, Deng HX, Chen YC, Guan XY, et al: EZH2 supports
ovarian carcinoma cell invasion and/or metastasis via regulation of
TGF-beta1 and is a predictor of outcome in ovarian carcinoma
patients. Carcinogenesis. 31:1576–1583. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nephew KP and Huang TH: Epigenetic gene
silencing in cancer initiation and progression. Cancer Lett.
190:125–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Archer SL, Marsboom G, Kim GH, Zhang HJ,
Toth PT, Svensson EC, Dyck JR, Gomberg-Maitland M, Thébaud B,
Husain AN, et al: Epigenetic attenuation of mitochondrial
superoxide dismutase 2 in pulmonary arterial hypertension: A basis
for excessive cell proliferation and a new therapeutic target.
Circulation. 121:2661–2671. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Philibert RA, Sears RA, Powers LS, Nash E,
Bair T, Gerke AK, Hassan I, Thomas CP, Gross TJ and Monick MM:
Coordinated DNA methylation and gene expression changes in smoker
alveolar macrophages: Specific effects on VEGF receptor 1
expression. J Leukoc Biol. 92:621–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aljubran SA, Cox R Jr, Tamarapu
Parthasarathy P, Kollongod Ramanathan G, Rajanbabu V, Bao H,
Mohapatra SS, Lockey R and Kolliputi N: Enhancer of zeste homolog 2
induces pulmonary artery smooth muscle cell proliferation. PLoS
One. 7:e377122012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stenmark KR, Fagan KA and Frid MG:
Hypoxia-induced pulmonary vascular remodeling: Cellular and
molecular mechanisms. Circ Res. 99:675–691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Groves BM, Reeves JT, Sutton JR, Wagner
PD, Cymerman A, Malconian MK, Rock PB, Young PM and Houston CS:
Operation everest II: Elevated high-altitude pulmonary resistance
unresponsive to oxygen. J Appl Physiol (1985). 63:521–530. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Galiè N and Kim NH: Pulmonary
microvascular disease in chronic thromboembolic pulmonary
hypertension. Proc Am Thorac Soc. 3:571–576. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barst RJ, McGoon M, Torbicki A, Sitbon O,
Krowka MJ, Olschewski H and Gaine S: Diagnosis and differential
assessment of pulmonary arterial hypertension. J Am Coll Cardiol.
43 (12 Suppl S):40S–47S. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Huang X, Leng D, Li J, Wang L,
Liang Y, Wang J, Miao R and Jiang T: DNA methylation signatures of
pulmonary arterial smooth muscle cells in chronic thromboembolic
pulmonary hypertension. Physiol Genomics. 50:313–322. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ogawa A, Firth AL, Yao W, Madani MM, Kerr
KM, Auger WR, Jamieson SW, Thistlethwaite PA and Yuan JX:
Inhibition of mTOR attenuates store-operated Ca2+ entry
in cells from endarterectomized tissues of patients with chronic
thromboembolic pulmonary hypertension. Am J Physiol Lung Cell Mol
Physiol. 297:L666–L676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rouillard AD, Gundersen GW, Fernandez NF,
Wang Z, Monteiro CD, McDermott MG and Ma'ayan A: The harmonizome: A
collection of processed datasets gathered to serve and mine
knowledge about genes and proteins. Database (Oxford).
2016:baw1002016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jassal B, Matthews L, Viteri G, Gong C,
Lorente P, Fabregat A, Sidiropoulos K, Cook J, Gillespie M, Haw R,
et al: The reactome pathway knowledgebase. Nucleic Acids Res.
48(D1): D498–D503. 2020.PubMed/NCBI
|
|
21
|
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong
S, Kong L, Gao G, Li CY and Wei L: KOBAS 2.0: A web server for
annotation and identification of enriched pathways and diseases.
Nucleic Acids Res. 39((Web Server Issue)): W316–W322. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Humbert M: Pulmonary arterial hypertension
and chronic thromboembolic pulmonary hypertension: Pathophysiology.
Eur Respir Rev. 19:59–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Czermin B, Melfi R, McCabe D, Seitz V,
Imhof A and Pirrotta V: Drosophila enhancer of Zeste/ESC complexes
have a histone H3 methyltransferase activity that marks chromosomal
Polycomb sites. Cell. 111:185–196. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bracken AP, Pasini D, Capra M, Prosperini
E, Colli E and Helin K: EZH2 is downstream of the pRB-E2F pathway,
essential for proliferation and amplified in cancer. EMBO J.
22:5323–5335. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang YX, Li JF, Yang YH, Zhai ZG, Gu S,
Liu Y, Miao R, Zhong PP, Wang Y, Huang XX, et al: Renin-angiotensin
system regulates pulmonary arterial smooth muscle cell migration in
chronic thromboembolic pulmonary hypertension. Am J Physiol Lung
Cell Mol Physiol. 314:L276–L286. 2018.PubMed/NCBI
|
|
26
|
Wang L, Liu J, Wang W, Qi X, Wang Y, Tian
B, Dai H, Wang J, Ning W, Yang T and Wang C: Targeting IL-17
attenuates hypoxia-induced pulmonary hypertension through
downregulation of β-catenin. Thorax. 74:564–578. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Varambally S, Cao Q, Mani RS, Shankar S,
Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, et al:
Genomic loss of microRNA-101 leads to overexpression of histone
methyltransferase EZH2 in cancer. Science. 322:1695–1699. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frid MG, Moiseeva EP and Stenmark KR:
Multiple phenotypically distinct smooth muscle cell populations
exist in the adult and developing bovine pulmonary arterial media
in vivo. Circ Res. 75:669–681. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pugliese SC, Poth JM, Fini MA, Olschewski
A, El Kasmi KC and Stenmark KR: The role of inflammation in hypoxic
pulmonary hypertension: From cellular mechanisms to clinical
phenotypes. Am J Physiol Lung Cell Mol Physiol. 308:L229–L252.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rose-John S: Interleukin-6 family
cytokines. Cold Spring Harb Perspect Biol. 10:a0284152018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karan D, Tawfik O and Dubey S: Expression
analysis of inflammasome sensors and implication of NLRP12
inflammasome in prostate cancer. Sci Rep. 7:43782017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Allen IC: Non-inflammasome forming NLRs in
inflammation and tumorigenesis. Front Immunol. 5:1692014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hermanns HM: Oncostatin M and
interleukin-31: Cytokines, receptors, signal transduction and
physiology. Cytokine Growth Factor Rev. 26:545–558. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miyata M, Ito M, Sasajima T, Ohira H and
Kasukawa R: Effect of a serotonin receptor antagonist on
interleukin-6-induced pulmonary hypertension in rats. Chest.
119:554–561. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Unver N and McAllister F: IL-6 family
cytokines: Key inflammatory mediators as biomarkers and potential
therapeutic targets. Cytokine Growth Factor Rev. 41:10–17. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ye RD and Sun L: Emerging functions of
serum amyloid A in inflammation. J Leukoc Biol. 98:923–929. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Helgadottir A, Manolescu A, Thorleifsson
G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ,
Gudmundsson G, Grant SF, Thorgeirsson G, et al: The gene encoding
5-lipoxygenase activating protein confers risk of myocardial
infarction and stroke. Nat Genet. 36:233–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Malle E, Sodin-Semrl S and Kovacevic A:
Serum amyloid A: An acute-phase protein involved in tumour
pathogenesis. Cell Mol Life Sci. 66:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
De Buck M, Gouwy M, Wang JM, Van Snick J,
Opdenakker G, Struyf S and Van Damme J: Structure and expression of
different serum amyloid a (SAA) variants and their
concentration-dependent functions during host insults. Curr Med
Chem. 23:1725–1755. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jumeau C, Awad F, Assrawi E, Cobret L,
Duquesnoy P, Giurgea I, Valeyre D, Grateau G, Amselem S, Bernaudin
JF and Karabina SA: Expression of SAA1, SAA2 and SAA4 genes in
human primary monocytes and monocyte-derived macrophages. PLoS One.
14:e02170052019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Barbacioru C, Hyland F, Xiao W,
Hunkapiller KL, Blake J, Chan F, Gonzalez C, Zhang L and Samaha RR:
Large scale real-time PCR validation on gene expression
measurements from two commercial long-oligonucleotide microarrays.
BMC Genomics. 7:592006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Soon E, Crosby A, Southwood M, Yang P,
Tajsic T, Toshner M, Appleby S, Shanahan CM, Bloch KD, Pepke-Zaba
J, et al: Bone morphogenetic protein receptor type II deficiency
and increased inflammatory cytokine production. A gateway to
pulmonary arterial hypertension. Am J Respir Crit Care Med.
192:859–872. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Humbert M, Monti G, Brenot F, Sitbon O,
Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G and
Emilie D: Increased interleukin-1 and interleukin-6 serum
concentrations in severe primary pulmonary hypertension. Am J
Respir Crit Care Med. 151:1628–1631. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Furuya Y, Satoh T and Kuwana M:
Interleukin-6 as a potential therapeutic target for pulmonary
arterial hypertension. Int J Rheumatol. 2010:7203052010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang X, Coriolan D, Murthy V, Schultz K,
Golenbock DT and Beasley D: Proinflammatory phenotype of vascular
smooth muscle cells: Role of efficient Toll-like receptor 4
signaling. Am J Physiol Heart Circ Physiol. 289:H1069–H1076. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bonnet S, Michelakis ED, Porter CJ,
Andrade-Navarro MA, Thébaud B, Bonnet S, Haromy A, Harry G, Moudgil
R, McMurtry MS, et al: An abnormal mitochondrial-hypoxia inducible
factor-1alpha-Kv channel pathway disrupts oxygen sensing and
triggers pulmonary arterial hypertension in fawn hooded rats:
Similarities to human pulmonary arterial hypertension. Circulation.
113:2630–2641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sutendra G and Michelakis ED: The
metabolic basis of pulmonary arterial hypertension. Cell Metab.
19:558–573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bonnet S, Archer SL, Allalunis-Turner J,
Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta
L, Bonnet S, et al: A mitochondria-K+ channel axis is
suppressed in cancer and its normalization promotes apoptosis and
inhibits cancer growth. Cancer Cell. 11:37–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Archer SL, Gomberg-Maitland M, Maitland
ML, Rich S, Garcia JG and Weir EK: Mitochondrial metabolism, redox
signaling, and fusion: A mitochondria-ROS-HIF-1alpha-Kv1.5
O2-sensing pathway at the intersection of pulmonary hypertension
and cancer. Am J Physiol Heart Circ Physiol. 294:H570–H578. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cho KA, Suh JW, Lee KH, Kang JL and Woo
SY: IL-17 and IL-22 enhance skin inflammation by stimulating the
secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1
pathway. Int Immunol. 24:147–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sutendra G, Dromparis P, Bonnet S, Haromy
A, McMurtry MS, Bleackley RC and Michelakis ED: Pyruvate
dehydrogenase inhibition by the inflammatory cytokine TNFα
contributes to the pathogenesis of pulmonary arterial hypertension.
J Mol Med (Berl). 89:771–783. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yasui K and Baba A: Therapeutic potential
of superoxide dismutase (SOD) for resolution of inflammation.
Inflamm Res. 55:359–363. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rabinovitch M, Guignabert C, Humbert M and
Nicolls MR: Inflammation and immunity in the pathogenesis of
pulmonary arterial hypertension. Circ Res. 115:165–175. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bauer EM, Zheng H, Comhair S, Erzurum S,
Billiar TR and Bauer PM: Complement C3 deficiency attenuates
chronic hypoxia-induced pulmonary hypertension in mice. PLoS One.
6:e285782011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang J, Zhang Y, Li N, Liu Z, Xiong C, Ni
X, Pu Y, Hui R, He J and Pu J: Potential diagnostic biomarkers in
serum of idiopathic pulmonary arterial hypertension. Respir Med.
103:1801–1806. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Langer F, Schramm R, Bauer M, Tscholl D,
Kunihara T and Schäfers HJ: Cytokine response to pulmonary
thromboendarterectomy. Chest. 126:135–141. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
von Haehling S, von Bardeleben RS, Kramm
T, Thiermann Y, Niethammer M, Doehner W, Anker SD, Munzel T, Mayer
E and Genth-Zotz S: Inflammation in right ventricular dysfunction
due to thromboembolic pulmonary hypertension. Int J Cardiol.
144:206–211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gu S, Su P, Yan J, Zhang X, An X, Gao J,
Xin R and Liu Y: Comparison of gene expression profiles and related
pathways in chronic thromboembolic pulmonary hypertension. Int J
Mol Med. 33:277–300. 2014. View Article : Google Scholar : PubMed/NCBI
|
